On January 16, 2026, the U.S. Patent and Trademark Office's Patent Trial and Appeal Board (“PTAB”) instituted two inter partes review (IPR) proceedings for Brooks Kushman client Ford Motor Company (“Ford”) and denied Patent Owner AutoConnect Holdings, LLC's request for discretionary denial in a third proceeding. See IPR2025‑01342, ‑01383, and ‑01524, Paper 11 (Jan. 16, 2026). Ford filed these IPRs challenging patents related to infotainment systems that AutoConnect asserted in district court. These decisions are especially significant given [...]

In Seagen v. Daiichi Sankyo1, the Federal Circuit invalidated claims in a life sciences patent, highlighting the limits of genus-level disclosure to support specific, non-exemplified species. The court found that generic disclosure of a small linker in antibody-drug conjugates (ADCs) of Seagen's application was not enough to describe the particular linker of Daiichi Sankyo's ADC, Enhertu®, and reversed a jury verdict that Enhertu® infringed Seagen's patent. The decision reinforces the demanding written description standard in [...]

Caldwell represents Solos Technology Ltd. in a patent infringement lawsuit filed in federal court concerning smart eyewear technologies. The lawsuit alleges unauthorized use of Solos' patented technologies and names Meta Platforms Inc. and EssilorLuxottica SA as defendants. The Bloomberg article below provides an overview of the claims, and a PDF of the court filing is linked below. Bloomberg article:  Meta, EssilorLuxottica Sued in Smart Glasses Patent Case Complaint: Solos Technology Limited v. Meta Platforms, Inc., Meta [...]